ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$0.55
0.00 (-0.16%)
As of Aug 15, 2:18 AM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 6 40%
Sell 0 0%
Price Target
Analyst Price Target +2,040.9% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $0.55
Current
$0.55
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
1,586.3%
Low target
Base Case
$11.82
+2,040.9%
Avg target
Bull Case
$19.97
+3,517.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$6.50
-91.5% from high
52-Week Low
$0.40
+39.8% from low
Target vs 52W High
$11.82
+81.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%